Form 4: Merit Medical Director Receives RSU Grant
Director Equity Grant
Director Michael R. McDonnell was granted 3,457 restricted stock units under the Merit Medical Systems 2026 Equity Incentive Plan.
Summary
- Director Michael R. McDonnell received a grant of 3,457 restricted stock units (RSUs).
- The grant was issued under the Merit Medical Systems, Inc. 2026 Equity Incentive Plan.
- The RSUs are scheduled to vest on May 3, 2027, contingent upon continued service to the company.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation with no material impact on company operations or financial outlook.
Positives
- Alignment of director interests with long-term shareholder value through equity-based compensation.
Negatives
- None identified.
Risks
- Vesting is subject to continued service, creating a dependency on the director's ongoing tenure.
Future Outlook
The filing does not provide forward-looking financial guidance, focusing solely on director equity compensation.
Industry Context
StockSavvy.ai notes that equity grants to directors are standard corporate governance practices in the medical device sector to ensure board alignment with shareholder interests.
Comparison to Industry Standards
- The use of RSU grants for board compensation is consistent with standard practices among mid-cap medical technology companies like Hologic or Teleflex.
- The vesting period of approximately one year is a common retention mechanism for board members.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Power of Attorney | Michael R. McDonnell authorized Brian G. Lloyd, Raul Parra Jr., and Matthew C. Fleming to file SEC documents on his behalf. | 10/03/2025 | Standard administrative procedure to facilitate timely regulatory compliance. |
Stakeholder Impact
- Minimal impact on shareholders; reflects standard board compensation practices.
Next Steps
- Vesting of the 3,457 RSUs on May 3, 2027.
Key Dates
| Date | Description |
|---|---|
| 10/03/2025 | Date of execution for the Power of Attorney. |
| 05/18/2026 | Date of the RSU grant transaction. |
| 05/03/2027 | Vesting date for the granted restricted stock units. |
Keywords
Merit Medical Systems, MMSI, Director Compensation, Restricted Stock Units, Equity Incentive Plan, Insider Transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.